You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
海正藥業(600267.SH):發行股份、可轉債及支付現金購買瀚暉製藥49%股權並募集資金方案獲浙江國資委批覆
格隆匯 09-17 18:17

格隆匯 9 月 17日丨海正藥業(600267.SH)公佈,公司擬通過發行股份、可轉換公司債券及支付現金購買HPPCHoldingSARL(以下簡稱“HPPC”)持有的瀚暉製藥有限公司(以下簡稱“瀚暉製藥”)49%股權(以下簡稱“本次交易”)。同時,公司擬通過向台州市椒江區國有資產經營有限公司非公開發行股份及向員工持股計劃定向發行可轉換公司債券的方式募集配套資金,募集配套資金總額不超過15億元,不超過本次擬以發行股份及可轉換公司債券方式購買資產的交易價格的100%,發行數量及價格按照中國證券監督管理委員會的相關規定確定。

公司於2020年9月17日收到浙江省人民政府國有資產監督管理委員會下發的《浙江省國資委關於浙江海正藥業股份有限公司發行股份、可轉換公司債券及支付現金購買資產並募集資金方案的批覆》(浙國資產權【2020】34號),內容如下:

一、原則同意浙江海正藥業股份有限公司發行股份、可轉換公司債券及支付現金購買資產並募集資金的方案。

二、同意浙江海正藥業股份有限公司向HPPCHoldingSARL發行股份143380114股、發行面值100元可轉換公司債券10152415張,以及支付現金購買HPPCHoldingSARL持有的瀚暉製藥有限公司49%股份;向台州市椒江區國有資產經營有限公司發行不超過59931506股股份、向海正藥業第一期員工持股計劃發行面值100元可轉換公司債券不超過800萬張,募集配套資金不超過15億元。

本次交易尚需提交公司股東大會審議,並經有權監管機構批准後方可正式實施,能否通過審批尚存在一定不確定性。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account